BioLife Solutions, Inc. (BLFS)
37.17
+0.48
(+1.31%)
USD |
NASDAQ |
Sep 21, 16:00
36.45
-0.72
(-1.94%)
After-Hours: 20:00
BioLife Solutions Price to Book Value : 4.327 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 4.271 |
| September 17, 2026 | 4.289 |
| September 16, 2026 | 4.203 |
| September 15, 2026 | 4.236 |
| September 14, 2026 | 4.124 |
| September 11, 2026 | 4.068 |
| September 10, 2026 | 4.065 |
| September 09, 2026 | 4.066 |
| September 08, 2026 | 4.118 |
| September 04, 2026 | 4.103 |
| September 03, 2026 | 4.136 |
| September 02, 2026 | 4.181 |
| September 01, 2026 | 4.129 |
| August 31, 2026 | 4.315 |
| August 28, 2026 | 4.235 |
| August 27, 2026 | 4.330 |
| August 26, 2026 | 4.307 |
| August 25, 2026 | 4.332 |
| August 24, 2026 | 4.329 |
| August 21, 2026 | 4.318 |
| August 20, 2026 | 4.303 |
| August 19, 2026 | 4.245 |
| August 18, 2026 | 4.067 |
| August 17, 2026 | 4.126 |
| August 14, 2026 | 4.082 |
| Date | Value |
|---|---|
| August 13, 2026 | 4.101 |
| August 12, 2026 | 4.071 |
| August 11, 2026 | 4.053 |
| August 10, 2026 | 4.032 |
| August 07, 2026 | 4.034 |
| August 06, 2026 | 3.950 |
| August 05, 2026 | 3.934 |
| August 04, 2026 | 3.785 |
| August 03, 2026 | 3.742 |
| July 31, 2026 | 3.641 |
| July 30, 2026 | 3.683 |
| July 29, 2026 | 3.667 |
| July 28, 2026 | 3.722 |
| July 27, 2026 | 3.468 |
| July 24, 2026 | 3.490 |
| July 23, 2026 | 3.582 |
| July 22, 2026 | 3.626 |
| July 21, 2026 | 3.398 |
| July 20, 2026 | 3.386 |
| July 17, 2026 | 3.393 |
| July 16, 2026 | 3.522 |
| July 15, 2026 | 3.393 |
| July 14, 2026 | 3.335 |
| July 13, 2026 | 3.271 |
| July 10, 2026 | 3.280 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Repligen Corp. | 4.828 |
| Agilent Technologies, Inc. | 6.208 |
| Danaher Corp. | 2.886 |
| Thermo Fisher Scientific, Inc. | 4.625 |
| West Pharmaceutical Services, Inc. | 8.516 |
Price to Book Value Related Metrics
| PE Ratio | 38.44 |
| PS Ratio | 17.74 |
| Price to Free Cash Flow | 228.36 |
| Price | 37.17 |
| Earnings Yield | 2.60% |
| Market Cap | 1.817B |
| Operating PE Ratio | 611.84 |
| Normalized PE Ratio | 38.44 |